FDA Grants Carmell Therapeutics Expedited Review for Bone Healing Accelerant

Carmell Therapeutics was granted Fast Track designation by FDA for the company’s Bone Healing Accelerant (BHA). Expedited review allows for more frequent meetings with FDA and rolling review for a Biologic License Application (BLA). Rolling review allows for a shorter period of time for approval after a clinical trial is complete.

At the close...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0